PROFILPELAJAR.COM

Landiolol
(IUPAC) ime
	[(4S)-2,2-dimetil-1,3-dioksolan-4-il]metil 3-[4-[(2S)-2-hidroksi-3-[2-(morfolin-4-karbonilamino)etilamino]propoksi]fenil]propanoat
Klinički podaci
AHFS/Drugs.com	Internacionalno ime leka
Identifikatori
CAS broj	133242-30-5
ATC kod	nije dodeljen
PubChem	114905
UNII	62NWQ924LH
Hemijski podaci
Formula	C25H39N3O8
Mol. masa	509,59 g/mol
SMILES	eMolekuli & PubHem
InChI
	InChI=1S/C25H39N3O8/c1-25(2)35-18-22(36-25)17-34-23(30)8-5-19-3-6-21(7-4-19)33-16-20(29)15-26-9-10-27-24(31)28-11-13-32-14-12-28/h3-4,6-7,20,22,26,29H,5,8-18H2,1-2H3,(H,27,31) ; Key: WMDSZGFJQKSLLH-UHFFFAOYSA-N
Farmakoinformacioni podaci
Trudnoća	?
Pravni status	℞ Prescription only
Način primene	IV

Landiolol je lek koji deluje kao visoko kardioselektivni, ultra kraktotrajni beta blokator. On se koristi kao antiaritmički agens.

Reference

↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.

Yoshiya I (December 1998). „[Landiolol hydrochloride, a new sympathetic beta blocker]” (Japanese). Masui 47 Suppl: S126–32. PMID 9921175.
Ogata J, Okamoto T, Minami K (2003). „Landiolol for the treatment of tachyarrhythmia associated with atrial fibrillation”. Can J Anaesth 50 (7): 753. DOI:10.1007/BF03018726. PMID 12944459.

	Portal Medicina
	Portal Hemija